Penserra Capital Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-310
| Closed | -$2K | – | 1191 |
|
|
2022
Q4 | $2K | Buy |
+310
| New | +$2K | ﹤0.01% | 1056 |
|
|
2021
Q4 | – | Sell |
-4,560
| Closed | -$116K | – | 1492 |
|
|
2021
Q3 | $116K | Buy |
4,560
+45
| +1% | +$1.15K | ﹤0.01% | 738 |
|
|
2021
Q2 | $157K | Buy |
4,515
+150
| +3% | +$5.22K | ﹤0.01% | 688 |
|
|
2021
Q1 | $145K | Buy |
4,365
+70
| +2% | +$2.33K | ﹤0.01% | 639 |
|
|
2020
Q4 | $111K | Buy |
4,295
+2,785
| +184% | +$72K | ﹤0.01% | 594 |
|
|
2020
Q3 | $14K | Buy |
+1,510
| New | +$14K | ﹤0.01% | 782 |
|